Senseonics Q1 revenue up 22% to $5.1M; net loss $18.9M vs income $1.3M

Senseonics Holdings, Inc.

2024-Q1 EPS reported -$0.03 revenue$5,047,000

Revenue $5.1M (+22% YoY); U.S. $3.7M (+76%), OUS $1.4M (-30%).
Net loss $18.9M ($0.03 diluted loss) vs net income $1.3M in Q1 2023, driven by non-cash derivative accounting.
First half 2024 revenue outlook unchanged at $10M (~16% growth YoY).
Received iCGM designation for Eversense; FDA 510(k) filed for 365-day system.
Collaboration with Mercy health system to manage 30,000 potential CGM users.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Senseonics Holdings, Inc. reported quarter ended March 31, 2024 results: revenue $5.1 million, net income Net loss was $18.9 million, or $0.03 per share, EPS $0.03 per share.

Period: quarter ended March 31, 2024
Revenue: $5.1 million
Net income: Net loss was $18.9 million, or $0.03 per share
EPS: $0.03 per share
Result: reported results

Exact text from the filing

Total revenue for the first quarter of 2024 was $5.1 million compared to $4.1 million for the first quarter of 2023.

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

Senseonics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-060535

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.